Horst Oexle - Concepedia

Author

Horst Oexle

Innsbruck Medical University

Also Known As

H. Oexle, Horst Oexle

Publications

598

Citations

H-Index

Concepts

All Affiliations

Innsbruck Medical University Klinikum Wels-Grieskirchen Krankenhaus der Elisabethinen Medical University of Vienna Military Medical Academy

About

Horst Oexle is an author at Innsbruck Medical University specializing in medicine, radiation oncology, and hematology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	459
2	Health Sciences	2	2	344
3	Biochemistry	1	1	298
4	Cell Biology	1	1	298
5	Immunology	1	1	46

Horst Oexle

Publications

587

Citations

H-Index

Page 1

	Year	Citations
Iron-dependent changes in cellular energy metabolism: influence on citric acid cycle and oxidative phosphorylation Horst Oexle, Erich Gnaiger Biochimica et Biophysica Acta (BBA) - Bioenergetics Cellular Energy MetabolismCitric Acid CycleEnergy MetabolismBiochemistryIron Metabolism	1999	298
Pathways for the regulation of interferon-γ-inducible genes by iron in human monocytic cells Horst Oexle, Arthur Kaser, Johannes Möst, Journal of Leukocyte Biology	2003	107
Bevacizumab plus chemotherapy continued beyond first progression in patients with metastatic colorectal cancer previously treated with bevacizumab plus chemotherapy: ML18147 study KRAS subgroup findings Stefan Kubicka, Richard Greil, Thierry André, Annals of Oncology Gastrointestinal OncologyMedicinePathologyColorectal CancerMetastatic Colorectal Cancer	2013	101
Rituximab maintenance versus observation alone in patients with chronic lymphocytic leukaemia who respond to first-line or second-line rituximab-containing chemoimmunotherapy: final results of the AGMT CLL-8a Mabtenance randomised trial Richard Greil, Petra Obrtlíková, Lukáš Smolej, The Lancet Haematology Hematological MalignancySecond-line Rituximab-containing ChemoimmunotherapyLymphoid NeoplasiaMedicineImmunology	2016	46
Janus‐faced course of COVID‐19 infection in patients with hematological malignancies Rosa Bellmann‐Weiler, Francesco Burkert, Theresa Schwaiger, European Journal Of Haematology Long CovidCovid-19 PandemicHematologyPathologyVirology	2020	14
Rituximab Maintenance after Chemoimmunotherapy Induction in 1st and 2nd Line Improves Progression Free Survival: Planned Interim Analysis of the International Randomized AGMT-CLL8/a Mabtenance Trial Richard Greil, Petra Obrtlíková, Lukáš Smolej, Blood	2014	11
Rituximab maintenance overcomes the negative prognostic factor of obesity in CLL: Subgroup analysis of the international randomized AGMT CLL‐8a mabtenance trial Alexander Egle, Thomas Melchardt, Petra Obrtlíková, Cancer Medicine	2019	10

Page 1